As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Dwivedi, Varun
Funded by
Triterpenoid Therapeutics
The major goal is to determine if CDDO-2p-lm inhibits uptake/entry, replication, and release of virus, as well as inhibiting cytopathic effects and excessive inflammation caused by virus (induction of excessive secretion of cytokines, "cytokine storm").
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Patterson, Jean L.
Funded by
National Institutes of Health
Collaborating Institutions
University of California Santa Cruz
Our goal is to provide SARS-2-CoV as RNA and as virus in bodily fluids. We will inoculate baboons with 1 X10^6 PFUs intra-nasally. Blood, urine, nasal swabs and feces samples will be taken every two days postinfection. Purified RNA from in vitro cultured virus will also be given for analysis.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Dwivedi, Varun
The major goal is to evaluate antiviral activity of CUSTOMER COMPOUND against SARS-CoV-2 in Vero cell lines.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Daadi, Marcel M
Funded by
National Institutes of Health
The overarching goal of this proposal is to establish the baboon as a relevant model of age-related cognitive impairment by validating behavioral, cognitive, and neuroanatomical features affected in aged baboons and identifying the appropriate miRNA biomarkers that may be causal of the age-related structural and functional changes.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Torrelles, Jordi B
Funded by
Airway Therapeutics
The goal is to determine the effectivity of AT-100 post-infection in blocking SARS-CoV-2 infectivity.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Kenneth Carson
Funded by
San Antonio Partnership for Precision Therapeutics
Collaborating Institutions
South Texas Center for Emerging Infectious Diseases
UT Health San Antonio
Texas Biomedical Research Institute
The San Antonio Partnership for Precision Therapeutics has awarded $200,000 for a collaborative study to develop a novel vaccine to combat COVID-19. Within days of the Stay Home/Work Safe directive issued by the City of San Antonio, the San Antonio Partnership for Precision Therapeutics (SAPPT) organized and issued a call for proposals to combat COVID-19.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Martinez-Sobrido, Luis
Collaborating Institutions
University of Rochester
Dr. Martinez-Sobrido will be responsible for the pandemic research plan that includes pre-pandemic risk assessment and emergency pandemic response plan.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Romero Uribe, Gabriela
Funded by
Natl Inst of Health
Cell-type specific manipulation of neural circuits is required for the treatment of neurological disorders such as epilepsy and Parkinson’s disease. Precise control of neural circuits will enable the development of neuromodulation therapies for these debilitating conditions. Existing technologies to control neural activity offer limited possibilities.
